These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cost benefit of pharmacy audit and nonrestrictive antibiotic policy. Ware GJ; Ford DJ N Z Med J; 1993 Apr; 106(954):160. PubMed ID: 8479665 [No Abstract] [Full Text] [Related]
9. Balancing the benefits and costs of antibiotic drugs: the TREAT model. Leibovici L; Paul M; Andreassen S Clin Microbiol Infect; 2010 Dec; 16(12):1736-9. PubMed ID: 20673259 [TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. Eckman MH; Steere AC; Kalish RA; Pauker SG N Engl J Med; 1997 Jul; 337(5):357-63. PubMed ID: 9233874 [No Abstract] [Full Text] [Related]
12. Antibiotic cycling can reduce resistance, but it may cost more--in the short run. Perform Improv Advis; 2005 May; 9(5):57-8, 49. PubMed ID: 15984154 [TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of an antimicrobial stewardship programme. Liew YX; Lee W; Kwa AL; Chlebicki MP Int J Antimicrob Agents; 2015 Nov; 46(5):594-5. PubMed ID: 26493229 [No Abstract] [Full Text] [Related]
14. [Scientific evidence and antimicrobial therapy: A perfect couple?]. Jovell AJ Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():9-14. PubMed ID: 10605184 [TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness analysis in cystic fibrosis. Doran C; Vos T J Cyst Fibros; 2005 Dec; 4(4):211-2. PubMed ID: 16230054 [No Abstract] [Full Text] [Related]
16. What are the antibiotics of choice for odontogenic infections, and how long should the treatment course last? Flynn TR Oral Maxillofac Surg Clin North Am; 2011 Nov; 23(4):519-36, v-vi. PubMed ID: 21982604 [TBL] [Abstract][Full Text] [Related]
17. [The other side of the coin: socioeconomic analysis of antibiotic resistance]. García-Altés A; Jovell AJ; Aymerich M Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():27-31. PubMed ID: 10605187 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of fidaxomicin for Clostridium difficile treatment. Simon MS Clin Infect Dis; 2014 Feb; 58(4):603. PubMed ID: 24300043 [No Abstract] [Full Text] [Related]